China Intraocular Lens (IOL) Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$3,250$7,500

Intraocular lens (IOL) is an eye-implanted lens used for the treatment of cataracts or myopia. The most prevalent form of IOL is pseudophakic IOL. These are inserted during cataract surgery, following removal of the blurry crystalline lens.

Clear

Description

China Intraocular Lens (IOL) Market By Type (Monofocal Intraocular Lens and Premium Intraocular Lens.); By Material (Polymethylmethacrylate (PMMA) and Foldable.); By End User (Hospitals and Ambulatory Surgery Centers, Specialty Clinics and Academic and Research Institutes) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030.

Product Overview
Intraocular lens (IOL) is an eye-implanted lens used for the treatment of cataracts or myopia. The most prevalent form of IOL is pseudophakic IOL. These are inserted during cataract surgery, following removal of the blurry crystalline lens. The pseudophakic IOL replaces the original crystalline lens and provides the light-focusing feature which the crystalline lens originally undertook. The second type of IOL, more generally referred to as a phakic intraocular lens (PIOL), is a lens that is mounted above the original natural lens and used in refractive surgery to modify the optical capacity of the eye as a treatment for myopia or near sight.

Market Highlights
China Intraocular Lens Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. Growth in geriatric population vulnerable to ocular conditions, rise in cataract prevalence and increase in government initiatives to reduce avoidable blindness are expected to drive growth in the global market for intraocular lenses. Furthermore, the rise in the adoption of premium lens due to its advantages such as improved visual clarity and reduced astigmatism supports market development.

China Intraocular Lens Market: Segments
China Intraocular Lens Market is segmented on the basis of type, material, end user and region.
By Type (in %), China Intraocular Lens Market, 2019
The Intraocular Premium lens segment is anticipated to register XX% of the market share during the forecasted period
By Type the market can be segmented into Monofocal Intraocular Lens and Premium Intraocular Lens.
Intraocular Premium lenses include multifocal, toric, and accommodative lenses. Advanced advantages provided by premium lenses include multifocal aperture, better visibility, and removal of the need for glass after cataract, and greater accuracy. These features, despite being comparatively more costly, are increasing their acceptance globally.

China Intraocular Lens Market Dynamics:

Government initiatives along with increased adoption to increase market growth

Growth in geriatric population vulnerable to ocular conditions, rise in cataract prevalence and increase in government initiatives to reduce avoidable blindness are expected to drive growth in the global market for intraocular lenses.
High costs and post-surgical complications to hinder the market growth in China

The demand for intraocular lenses is affected by high costs associated with cataract care and inadequate coverage of both conventional and advanced procedures. In addition, post-surgical complications also threaten to constrain development.

China Intraocular Lens Market: Regions
In terms of value and volume, China accounted for XX% of total market volume share in 2019
With the increase in the geriatric population along with diabetic population in developed countries, cataract and other retinal procedures are more commonly accepted, thus increasing the demand for intraocular lenses in China. In addition, policy initiatives to develop and market cost-effective treatment options, and joint efforts by private and government agencies to create eye care facilities are driving market growth in the region.

China Intraocular Lens Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Intraocular Lens Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developing regions.

China Intraocular Lens Market: Key players

• Alcon
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Bausch & Lomb
• CARL Zeiss
• HumanOptics
• Rayner
• STAAR Surgical
• Haohai Biological Technology
• Eyebright Medical
• Wuxi Vision Pro Ltd
• Other prominent players

China Intraocular Lens Market report also contains analysis on:

China Intraocular Lens Market segments: –

• By Type:

o Monofocal Intraocular Lens
o Premium Intraocular Lens

• By Material:

o Polymethylmethacrylate (PMMA)
o Foldable
• By End User
o Hospitals and Ambulatory Surgery Centers
o Specialty Clinics
o Academic and Research Institutes

• China Intraocular Lens Market dynamics
• China Intraocular Lens Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Related  reports:

Global Contact and Intraocular Lenses Market Research Report—Forecast till 2025

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

1. Executive Summary
2. China Intraocular Lens Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Correlation & Regression Analysis
6.1. Correlation Matrix
6.2. Regression Matrix
7. Recent Development, Policies & Regulatory Landscape
8. Risk Analysis
8.1. Demand Risk Analysis
8.2. Supply Risk Analysis
9. China Intraocular Lens Market Analysis
9.1. Porters Five Forces
9.1.1. Threat of New Entrants
9.1.2. Bargaining Power of Suppliers
9.1.3. Threat of Substitutes
9.1.4. Rivalry
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. China Intraocular Lens Market
10.1. Market Size & forecast, 2019A-2030F
10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. China Intraocular Lens Market: Market Segmentation

11.1.1. East China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. South China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.3. North China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.4. West China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. China Intraocular Lens Market: Market Segmentation
12.1. By type: Market Share (2020-2030F)
12.1.1. Monofocal Intraocular Lens, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Premium Intraocular Lens, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By material: Market Share (2020-2030F)
12.2.1. Polymethylmethacrylate (PMMA), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Foldable, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By end user: Market Share (2020-2030F)
12.3.1. Hospitals and ambulatory surgery centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Specialty Clinics and Academic, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Research Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. Company Profile
13.1. Alcon
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Bausch & Lomb
13.3. CARL Zeiss
13.4. HumanOptics
13.5. Rayner
13.6. STAAR Surgical
13.7. Haohai Biological Technology
13.8. Eyebright Medical
13.9. Wuxi Vision Pro Ltd
13.10. Other prominent players

14. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

RSS
Follow by Email